Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2018 | 10-2017 | 07-2017 | 04-2017 | 01-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,176 | 570 | 4,847 | -7,716 | -34,393 |
| Depreciation Amortization | 320 | 132 | 82 | 33 | 78 |
| Accounts receivable | N/A | N/A | N/A | N/A | 658 |
| Accounts payable and accrued liabilities | 4,392 | -109 | -630 | -1,034 | 1,088 |
| Other Working Capital | -10,541 | -10,809 | -5,766 | -3,894 | 42,588 |
| Other Operating Activity | 889 | -1,599 | 3,509 | 2,322 | 6,225 |
| Operating Cash Flow | $-19,116 | $-11,815 | $2,042 | $-10,289 | $16,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -469 | -530 | -471 | -362 | -108 |
| Net Acquisitions | -6,214 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -155 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -139 | 4 | 3 | 1 | 1 |
| Investing Cash Flow | $-6,822 | $-526 | $-468 | $-361 | $-107 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,941 | 20,352 | 32 | 4 | 379 |
| Other Financing Activity | -1,845 | -1,884 | 13 | 13 | 174 |
| Financing Cash Flow | $18,096 | $18,468 | $45 | $17 | $553 |
| Exchange Rate Effect | -2,517 | -1,146 | -1,317 | -624 | -958 |
| Beginning Cash Position | 36,520 | 37,269 | 37,031 | 36,307 | 21,813 |
| End Cash Position | 26,161 | 42,250 | 37,333 | 25,050 | 37,544 |
| Net Cash Flow | $-10,359 | $4,981 | $302 | $-11,257 | $15,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,116 | -11,815 | 2,042 | -10,289 | 16,243 |
| Capital Expenditure | -469 | -530 | -471 | -362 | -108 |
| Free Cash Flow | -19,585 | -12,345 | 1,571 | -10,651 | 16,135 |